APO Research, Inc.

APO RESEARCH · REPORT

Captopril API

Selected research

Industry Growth & Trends

Global Captopril API Industry Growth and Trends Forecast to 2032

Market perspective

The global Captopril API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Captopril API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Captopril API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Captopril API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Captopril API include Huahai Pharmaceutical, Changming Pharmaceutical, Weifang Pharmaceutical, Taicang Pharmaceutical, Poly Pharmaceutical, Yichuang Pharmaceutical, Wockhardt, Tecoland and Quimica Sintetica, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Captopril API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Captopril API market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Captopril API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Captopril API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Captopril API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Captopril API Market by Company

Huahai Pharmaceutical

Changming Pharmaceutical

Weifang Pharmaceutical

Taicang Pharmaceutical

Poly Pharmaceutical

Yichuang Pharmaceutical

Wockhardt

Tecoland

Quimica Sintetica

Medichem

Farmhispania

Egis Pharmaceuticals

Azelis Deutschland Pharma

Captopril API Segment by Type

98% Captopril API

99% Captopril API

Other

Captopril API Segment by Application

Compound Captopril Tablet

Captopril Tablet

Captopril Injection

Captopril API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Captopril API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Captopril API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Captopril API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Captopril API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Captopril API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 98% Captopril API Table 2. Major Company of 99% Captopril API Table 3. Major Company of Other Table 4. Global Captopril API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Captopril API Sales by Type (2021-2026) & (K Units) Table 6. Global Captopril API Sales Market Share in Volume by Type (2021-2026) Table 7. Global Captopril API Sales by Type (2021-2026) & (US$ Million) Table 8. Global Captopril API Sales Market Share in Value by Type (2021-2026) Table 9. Global Captopril API Price by Type (2021-2026) & (US$/Unit) Table 10. Global Captopril API Sales by Type (2027-2032) & (K Units) Table 11. Global Captopril API Sales Market Share in Volume by Type (2027-2032) Table 12. Global Captopril API Sales by Type (2027-2032) & (US$ Million) Table 13. Global Captopril API Sales Market Share in Value by Type (2027-2032) Table 14. Global Captopril API Price by Type (2027-2032) & (US$/Unit) Table 15. North America Captopril API Sales by Type (2021-2026) & (K Units) Table 16. North America Captopril API Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Captopril API Sales by Type (2021-2026) & (K Units) Table 18. Europe Captopril API Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Captopril API Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Captopril API Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Captopril API Sales by Type (2021-2026) & (K Units) Table 22. Latin America Captopril API Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Captopril API Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Captopril API Sales by Type (2021-2026) & (US$ Million) Table 25. Captopril API Industry Trends Table 26. Captopril API Industry Drivers Table 27. Captopril API Industry Opportunities and Challenges Table 28. Captopril API Industry Restraints Table 29. Global Captopril API Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Captopril API Revenue Market Share by Company (2021-2026) Table 31. Global Captopril API Sales by Company (2021-2026) & (K Units) Table 32. Global Captopril API Sales Share by Company (2021-2026) Table 33. Global Captopril API Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Captopril API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Captopril API Major Company Production Sites and Headquarters Table 36. Global Captopril API Company, Product Type & Application Table 37. Global Captopril API Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Captopril API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Captopril API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Captopril API Sales by Region (2021-2026) & (K Units) Table 42. Global Captopril API Sales Market Share in Volume by Region (2021-2026) Table 43. Global Captopril API Sales by Region (2021-2026) & (US$ Million) Table 44. Global Captopril API Sales Market Share in Value by Region (2021-2026) Table 45. Global Captopril API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Captopril API Sales by Region (2027-2032) & (K Units) Table 47. Global Captopril API Sales Market Share in Volume by Region (2027-2032) Table 48. Global Captopril API Sales by Region (2027-2032) & (US$ Million) Table 49. Global Captopril API Sales Market Share in Value by Region (2027-2032) Table 50. Global Captopril API Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Captopril API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Captopril API Sales by Application (2021-2026) & (K Units) Table 53. Global Captopril API Sales Market Share in Volume by Application (2021-2026) Table 54. Global Captopril API Sales by Application (2021-2026) & (US$ Million) Table 55. Global Captopril API Sales Market Share in Value by Application (2021-2026) Table 56. Global Captopril API Price by Application (2021-2026) & (US$/Unit) Table 57. Global Captopril API Sales by Application (2027-2032) & (K Units) Table 58. Global Captopril API Sales Market Share in Volume by Application (2027-2032) Table 59. Global Captopril API Sales by Application (2027-2032) & (US$ Million) Table 60. Global Captopril API Sales Market Share in Value by Application (2027-2032) Table 61. Global Captopril API Price by Application (2027-2032) & (US$/Unit) Table 62. North America Captopril API Sales by Application (2021-2026) & (K Units) Table 63. North America Captopril API Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Captopril API Sales by Application (2021-2026) & (K Units) Table 65. Europe Captopril API Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Captopril API Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Captopril API Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Captopril API Sales by Application (2021-2026) & (K Units) Table 69. Latin America Captopril API Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Captopril API Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Captopril API Sales by Application (2021-2026) & (US$ Million) Table 72. Huahai Pharmaceutical Company Information Table 73. Huahai Pharmaceutical Business Overview Table 74. Huahai Pharmaceutical Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Huahai Pharmaceutical Captopril API Product Portfolio Table 76. Huahai Pharmaceutical Recent Development Table 77. Changming Pharmaceutical Company Information Table 78. Changming Pharmaceutical Business Overview Table 79. Changming Pharmaceutical Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Changming Pharmaceutical Captopril API Product Portfolio Table 81. Changming Pharmaceutical Recent Development Table 82. Weifang Pharmaceutical Company Information Table 83. Weifang Pharmaceutical Business Overview Table 84. Weifang Pharmaceutical Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Weifang Pharmaceutical Captopril API Product Portfolio Table 86. Weifang Pharmaceutical Recent Development Table 87. Taicang Pharmaceutical Company Information Table 88. Taicang Pharmaceutical Business Overview Table 89. Taicang Pharmaceutical Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Taicang Pharmaceutical Captopril API Product Portfolio Table 91. Taicang Pharmaceutical Recent Development Table 92. Poly Pharmaceutical Company Information Table 93. Poly Pharmaceutical Business Overview Table 94. Poly Pharmaceutical Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Poly Pharmaceutical Captopril API Product Portfolio Table 96. Poly Pharmaceutical Recent Development Table 97. Yichuang Pharmaceutical Company Information Table 98. Yichuang Pharmaceutical Business Overview Table 99. Yichuang Pharmaceutical Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Yichuang Pharmaceutical Captopril API Product Portfolio Table 101. Yichuang Pharmaceutical Recent Development Table 102. Wockhardt Company Information Table 103. Wockhardt Business Overview Table 104. Wockhardt Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Wockhardt Captopril API Product Portfolio Table 106. Wockhardt Recent Development Table 107. Tecoland Company Information Table 108. Tecoland Business Overview Table 109. Tecoland Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Tecoland Captopril API Product Portfolio Table 111. Tecoland Recent Development Table 112. Quimica Sintetica Company Information Table 113. Quimica Sintetica Business Overview Table 114. Quimica Sintetica Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Quimica Sintetica Captopril API Product Portfolio Table 116. Quimica Sintetica Recent Development Table 117. Medichem Company Information Table 118. Medichem Business Overview Table 119. Medichem Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Medichem Captopril API Product Portfolio Table 121. Medichem Recent Development Table 122. Farmhispania Company Information Table 123. Farmhispania Business Overview Table 124. Farmhispania Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. Farmhispania Captopril API Product Portfolio Table 126. Farmhispania Recent Development Table 127. Egis Pharmaceuticals Company Information Table 128. Egis Pharmaceuticals Business Overview Table 129. Egis Pharmaceuticals Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Egis Pharmaceuticals Captopril API Product Portfolio Table 131. Egis Pharmaceuticals Recent Development Table 132. Azelis Deutschland Pharma Company Information Table 133. Azelis Deutschland Pharma Business Overview Table 134. Azelis Deutschland Pharma Captopril API Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Azelis Deutschland Pharma Captopril API Product Portfolio Table 136. Azelis Deutschland Pharma Recent Development Table 137. North America Captopril API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 138. North America Captopril API Sales by Country (2021-2026) & (K Units) Table 139. North America Captopril API Sales Market Share by Country (2021-2026) Table 140. North America Captopril API Sales Forecast by Country (2027-2032) & (K Units) Table 141. North America Captopril API Sales Market Share Forecast by Country (2027-2032) Table 142. North America Captopril API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. North America Captopril API Market Size by Country (2021-2026) & (US$ Million) Table 144. North America Captopril API Market Share by Country (2021-2026) Table 145. North America Captopril API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. North America Captopril API Market Share Forecast by Country (2027-2032) Table 147. Europe Captopril API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 148. Europe Captopril API Sales by Country (2021-2026) & (K Units) Table 149. Europe Captopril API Sales Market Share by Country (2021-2026) Table 150. Europe Captopril API Sales Forecast by Country (2027-2032) & (K Units) Table 151. Europe Captopril API Sales Market Share Forecast by Country (2027-2032) Table 152. Europe Captopril API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Europe Captopril API Market Size by Country (2021-2026) & (US$ Million) Table 154. Europe Captopril API Market Share by Country (2021-2026) Table 155. Europe Captopril API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Europe Captopril API Market Share Forecast by Country (2027-2032) Table 157. Asia-Pacific Captopril API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 158. Asia-Pacific Captopril API Sales by Country (2021-2026) & (K Units) Table 159. Asia-Pacific Captopril API Sales Market Share by Country (2021-2026) Table 160. Asia-Pacific Captopril API Sales Forecast by Country (2027-2032) & (K Units) Table 161. Asia-Pacific Captopril API Sales Market Share Forecast by Country (2027-2032) Table 162. Asia-Pacific Captopril API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Asia-Pacific Captopril API Market Size by Country (2021-2026) & (US$ Million) Table 164. Asia-Pacific Captopril API Market Share by Country (2021-2026) Table 165. Asia-Pacific Captopril API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Asia-Pacific Captopril API Market Share Forecast by Country (2027-2032) Table 167. Latin America Captopril API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 168. Latin America Captopril API Sales by Country (2021-2026) & (K Units) Table 169. Latin America Captopril API Sales Market Share by Country (2021-2026) Table 170. Latin America Captopril API Sales Forecast by Country (2027-2032) & (K Units) Table 171. Latin America Captopril API Sales Market Share Forecast by Country (2027-2032) Table 172. Latin America Captopril API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Latin America Captopril API Market Size by Country (2021-2026) & (US$ Million) Table 174. Latin America Captopril API Market Share by Country (2021-2026) Table 175. Latin America Captopril API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Latin America Captopril API Market Share Forecast by Country (2027-2032) Table 177. Middle East and Africa Captopril API Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 178. Middle East and Africa Captopril API Sales by Country (2021-2026) & (K Units) Table 179. Middle East and Africa Captopril API Sales Market Share by Country (2021-2026) Table 180. Middle East and Africa Captopril API Sales Forecast by Country (2027-2032) & (K Units) Table 181. Middle East and Africa Captopril API Sales Market Share Forecast by Country (2027-2032) Table 182. Middle East and Africa Captopril API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 183. Middle East and Africa Captopril API Market Size by Country (2021-2026) & (US$ Million) Table 184. Middle East and Africa Captopril API Market Share by Country (2021-2026) Table 185. Middle East and Africa Captopril API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 186. Middle East and Africa Captopril API Market Share Forecast by Country (2027-2032) Table 187. Key Raw Materials Table 188. Raw Materials Key Suppliers Table 189. Captopril API Distributors List Table 190. Captopril API Customers List Table 191. Research Programs/Design for This Report Table 192. Authors List of This Report Table 193. Secondary Sources Table 194. Primary Sources List of Figures Figure 1. Captopril API Image Figure 2. Global Captopril API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Captopril API Market Size (2021-2032) & (US$ Million) Figure 4. Global Captopril API Sales (2021-2032) & (K Units) Figure 5. 98% Captopril API Image Figure 6. Global 98% Captopril API Sales YoY Growth (2021-2032) & (K Units) Figure 7. 99% Captopril API Image Figure 8. Global 99% Captopril API Sales YoY Growth (2021-2032) & (K Units) Figure 9. Other Image Figure 10. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Captopril API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Captopril API Market Share by Type 2025 VS 2032 Figure 13. North America Captopril API Sales Market Share in Volume by Type in 2025 Figure 14. North America Captopril API Sales Market Share in Value by Type in 2025 Figure 15. Europe Captopril API Sales Market Share in Volume by Type in 2025 Figure 16. Europe Captopril API Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Captopril API Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Captopril API Sales Market Share in Value by Type in 2025 Figure 19. Latin America Captopril API Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Captopril API Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Captopril API Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Captopril API Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Captopril API Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Compound Captopril Tablet Image Figure 26. Global Compound Captopril Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 27. Captopril Tablet Image Figure 28. Global Captopril Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 29. Captopril Injection Image Figure 30. Global Captopril Injection Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Captopril API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Captopril API Market Share by Application 2025 VS 2032 Figure 33. North America Captopril API Sales Market Share in Volume by Application in 2025 Figure 34. North America Captopril API Sales Market Share in Value by Application in 2025 Figure 35. Europe Captopril API Sales Market Share in Volume by Application in 2025 Figure 36. Europe Captopril API Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Captopril API Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Captopril API Sales Market Share in Value by Application in 2025 Figure 39. Latin America Captopril API Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Captopril API Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Captopril API Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Captopril API Sales Market Share in Value by Application in 2025 Figure 43. North America Captopril API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Captopril API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Captopril API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Captopril API Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Captopril API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Captopril API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Captopril API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Captopril API Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Captopril API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Captopril API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Captopril API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Captopril API Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Captopril API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Captopril API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Captopril API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Captopril API Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Captopril API Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Captopril API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Captopril API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Captopril API Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Captopril API Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Captopril API Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 98% Captopril API
  • 99% Captopril API
  • Other
Applications
  • Compound Captopril Tablet
  • Captopril Tablet
  • Captopril Injection
Companies covered
  • Huahai Pharmaceutical
  • Changming Pharmaceutical
  • Weifang Pharmaceutical
  • Taicang Pharmaceutical
  • Poly Pharmaceutical
  • Yichuang Pharmaceutical
  • Wockhardt
  • Tecoland
  • Quimica Sintetica
  • Medichem
  • Farmhispania
  • Egis Pharmaceuticals
  • Azelis Deutschland Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Captopril API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Captopril API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Captopril API Market by Type
  6. 1.3.1 98% Captopril API
  7. 1.3.2 99% Captopril API
  8. 1.3.3 Other
  9. 1.4 Global Captopril API Market Size by Type
  10. 1.4.1 Global Captopril API Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Captopril API Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Captopril API Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Captopril API Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Captopril API Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Captopril API Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Captopril API Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Captopril API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Captopril API Industry Trends
  2. 2.2 Captopril API Industry Drivers
  3. 2.3 Captopril API Industry Opportunities and Challenges
  4. 2.4 Captopril API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Captopril API Revenue (2021-2026)
  2. 3.2 Global Top Players by Captopril API Sales (2021-2026)
  3. 3.3 Global Top Players by Captopril API Price (2021-2026)
  4. 3.4 Global Captopril API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Captopril API Major Company Production Sites & Headquarters
  6. 3.6 Global Captopril API Company, Product Type & Application
  7. 3.7 Global Captopril API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Captopril API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Captopril API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Captopril API Tier 1, Tier 2, and Tier 3
4 Captopril API Regional Status and Outlook
  1. 4.1 Global Captopril API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Captopril API Historic Market Size by Region
  3. 4.2.1 Global Captopril API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Captopril API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Captopril API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Captopril API Forecasted Market Size by Region
  7. 4.3.1 Global Captopril API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Captopril API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Captopril API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Captopril API by Application
  1. 5.1 Captopril API Market by Application
  2. 5.1.1 Compound Captopril Tablet
  3. 5.1.2 Captopril Tablet
  4. 5.1.3 Captopril Injection
  5. 5.2 Global Captopril API Market Size by Application
  6. 5.2.1 Global Captopril API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Captopril API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Captopril API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Captopril API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Captopril API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Captopril API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Captopril API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Captopril API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Huahai Pharmaceutical
  2. 6.1.1 Huahai Pharmaceutical Company Information
  3. 6.1.2 Huahai Pharmaceutical Business Overview
  4. 6.1.3 Huahai Pharmaceutical Captopril API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Huahai Pharmaceutical Captopril API Product Portfolio
  6. 6.1.5 Huahai Pharmaceutical Recent Developments
  7. 6.2 Changming Pharmaceutical
  8. 6.2.1 Changming Pharmaceutical Company Information
  9. 6.2.2 Changming Pharmaceutical Business Overview
  10. 6.2.3 Changming Pharmaceutical Captopril API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Changming Pharmaceutical Captopril API Product Portfolio
  12. 6.2.5 Changming Pharmaceutical Recent Developments
  13. 6.3 Weifang Pharmaceutical
  14. 6.3.1 Weifang Pharmaceutical Company Information
  15. 6.3.2 Weifang Pharmaceutical Business Overview
  16. 6.3.3 Weifang Pharmaceutical Captopril API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Weifang Pharmaceutical Captopril API Product Portfolio
  18. 6.3.5 Weifang Pharmaceutical Recent Developments
  19. 6.4 Taicang Pharmaceutical
  20. 6.4.1 Taicang Pharmaceutical Company Information
  21. 6.4.2 Taicang Pharmaceutical Business Overview
  22. 6.4.3 Taicang Pharmaceutical Captopril API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Taicang Pharmaceutical Captopril API Product Portfolio
  24. 6.4.5 Taicang Pharmaceutical Recent Developments
  25. 6.5 Poly Pharmaceutical
  26. 6.5.1 Poly Pharmaceutical Company Information
  27. 6.5.2 Poly Pharmaceutical Business Overview
  28. 6.5.3 Poly Pharmaceutical Captopril API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Poly Pharmaceutical Captopril API Product Portfolio
  30. 6.5.5 Poly Pharmaceutical Recent Developments
  31. 6.6 Yichuang Pharmaceutical
  32. 6.6.1 Yichuang Pharmaceutical Company Information
  33. 6.6.2 Yichuang Pharmaceutical Business Overview
  34. 6.6.3 Yichuang Pharmaceutical Captopril API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Yichuang Pharmaceutical Captopril API Product Portfolio
  36. 6.6.5 Yichuang Pharmaceutical Recent Developments
  37. 6.7 Wockhardt
  38. 6.7.1 Wockhardt Company Information
  39. 6.7.2 Wockhardt Business Overview
  40. 6.7.3 Wockhardt Captopril API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Wockhardt Captopril API Product Portfolio
  42. 6.7.5 Wockhardt Recent Developments
  43. 6.8 Tecoland
  44. 6.8.1 Tecoland Company Information
  45. 6.8.2 Tecoland Business Overview
  46. 6.8.3 Tecoland Captopril API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Tecoland Captopril API Product Portfolio
  48. 6.8.5 Tecoland Recent Developments
  49. 6.9 Quimica Sintetica
  50. 6.9.1 Quimica Sintetica Company Information
  51. 6.9.2 Quimica Sintetica Business Overview
  52. 6.9.3 Quimica Sintetica Captopril API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Quimica Sintetica Captopril API Product Portfolio
  54. 6.9.5 Quimica Sintetica Recent Developments
  55. 6.10 Medichem
  56. 6.10.1 Medichem Company Information
  57. 6.10.2 Medichem Business Overview
  58. 6.10.3 Medichem Captopril API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Medichem Captopril API Product Portfolio
  60. 6.10.5 Medichem Recent Developments
  61. 6.11 Farmhispania
  62. 6.11.1 Farmhispania Company Information
  63. 6.11.2 Farmhispania Business Overview
  64. 6.11.3 Farmhispania Captopril API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Farmhispania Captopril API Product Portfolio
  66. 6.11.5 Farmhispania Recent Developments
  67. 6.12 Egis Pharmaceuticals
  68. 6.12.1 Egis Pharmaceuticals Company Information
  69. 6.12.2 Egis Pharmaceuticals Business Overview
  70. 6.12.3 Egis Pharmaceuticals Captopril API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Egis Pharmaceuticals Captopril API Product Portfolio
  72. 6.12.5 Egis Pharmaceuticals Recent Developments
  73. 6.13 Azelis Deutschland Pharma
  74. 6.13.1 Azelis Deutschland Pharma Company Information
  75. 6.13.2 Azelis Deutschland Pharma Business Overview
  76. 6.13.3 Azelis Deutschland Pharma Captopril API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Azelis Deutschland Pharma Captopril API Product Portfolio
  78. 6.13.5 Azelis Deutschland Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Captopril API Sales by Country
  2. 7.1.1 North America Captopril API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Captopril API Sales by Country (2021-2026)
  4. 7.1.3 North America Captopril API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Captopril API Market Size by Country
  6. 7.2.1 North America Captopril API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Captopril API Market Size by Country (2021-2026)
  8. 7.2.3 North America Captopril API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Captopril API Sales by Country
  2. 8.1.1 Europe Captopril API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Captopril API Sales by Country (2021-2026)
  4. 8.1.3 Europe Captopril API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Captopril API Market Size by Country
  6. 8.2.1 Europe Captopril API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Captopril API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Captopril API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Captopril API Sales by Country
  2. 9.1.1 Asia-Pacific Captopril API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Captopril API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Captopril API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Captopril API Market Size by Country
  6. 9.2.1 Asia-Pacific Captopril API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Captopril API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Captopril API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Captopril API Sales by Country
  2. 10.1.1 South America Captopril API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Captopril API Sales by Country (2021-2026)
  4. 10.1.3 South America Captopril API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Captopril API Market Size by Country
  6. 10.2.1 South America Captopril API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Captopril API Market Size by Country (2021-2026)
  8. 10.2.3 South America Captopril API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Captopril API Sales by Country
  2. 11.1.1 Middle East and Africa Captopril API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Captopril API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Captopril API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Captopril API Market Size by Country
  6. 11.2.1 Middle East and Africa Captopril API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Captopril API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Captopril API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Captopril API Value Chain Analysis
  2. 12.1.1 Captopril API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Captopril API Production Mode & Process
  7. 12.2 Captopril API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Captopril API Distributors
  10. 12.2.3 Captopril API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.